期刊文献+

STAT3基因沉默降低小鼠乳腺癌细胞的体外迁移能力 被引量:4

STAT3 Silencing Inhibits Migration of Murine Breast Cancer Cells in vitro
原文传递
导出
摘要 信号转导子与转录活化子3(STAT3)是一个具有信号转导和转录调控双重功能的转录因子,有文献报道STAT3在乳腺癌中的表达显著升高,并能促进乳腺癌的转移。为了深入探索STAT3在肿瘤发生发展中的作用和影响乳腺癌转移的分子机制,采用RNA干扰技术在小鼠乳腺癌细胞株4T1中沉默STAT3的表达。MTT实验结果显示STAT3沉默对4T1细胞的增殖能力没有影响;细胞迁移实验结果表明STAT3表达被沉默后4T1细胞的迁移能力明显被抑制;定量PCR结果显示,STAT3基因沉默后4T1细胞中VEGF和IL-6的mRNA水平下降,E-cadherin表达上升,mosin表达下降;信号通路检测显示STAT3基因表达沉默后MAPK的活化明显降低。研究表明STAT3在小鼠乳腺癌细胞的迁移过程中发挥重要作用,为以STAT3基因为靶向的治疗提供了一定的实验依据。 STAT3(signal transducer and activator of transcription 3)is a dual functional transcription factor with functions as signal transduction and transcription regulation.There are reports that the expression of STAT3 in breast cancer is significantly higher and STAT3 can facilitate breast cancer metastasis.To clarify the definite effect and molecular mechanism of STAT3's involvement in breast cancer metastasis,STAT3 was silenced by RNAi in the murine highly metastatic 4T1 cells.The silencing of STAT3 didn't affect the proliferation rate of breast cancer 4T1 cells in MTT assay.However,the migration activity of STAT3 knockdown cells was strongly reduced in Transwell assay.The real-time quantitative PCR results indicated that STAT3 silencing significantly suppressed the expression of VEGF,IL-6 and mosin,while increased E-cadherin expression.Western blot assay showed that phosphorylation level of MAPK was reduced in STAT3 knockdown cells.The results demonstrate that STAT3 plays an important role in breast cancer metastasis and provide experimental evidences in therapy with STAT3 as a target.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2010年第6期1-7,共7页 China Biotechnology
基金 国家"973"计划资助项目(2003CB716402)
关键词 STAT3 乳腺癌 RNA干扰 细胞迁移 STAT3 Breast cancer RNAi Tumor migration
  • 相关文献

参考文献1

二级参考文献15

  • 1Vernooij E Heintz P, Witteveen E, van der Graaf Y. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol 2007, 105:801-812.
  • 2Burke WM, Jin X, Lin H J, Huang M, Liu R, Reynolds RK, Lin Jet al. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene 2001,20: 7925- 7934.
  • 3Silver DL, Naora H, Liu J, Cheng W, Montell DJ. Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res 2004, 64:3550-3558.
  • 4Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000, 19:2474-2488.
  • 5Nefedova Y, Gabrilovich DI. Targeting of Jak/STAT pathway in antigen presenting cells in cancer. Curt Cancer Drug Targets 2007, 7:71-77.
  • 6Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 2002, 99:6047-6052.
  • 7Germain D, Frank DA. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin Cancer Res 2007, 13:5665-5669.
  • 8Zhang X, Darnell JE Jr. Functional importance of Stat3 tetramerization in activation of the α 2-macroglobulin gene. J Biol Chem 2001, 276:33576-33581.
  • 9Germain D, Frank DA. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin Cancer Res 2007, 13; 5665-5669.
  • 10Deng J, Grande F, Neamati N. Small molecule inhibitors of Stat3 signaling pathway. Curr Cancer Drug Targets 2007, 7:91-107.

共引文献17

同被引文献43

  • 1于月新,李巨.紫草素逆转绒癌细胞JAR/MTX耐药与survivin和Bcl-2表达关系研究[J].第三军医大学学报,2007,29(19):1880-1882. 被引量:10
  • 2Ray A. Adipokine leptin in obesity-related pathology of breast cancer[J]. J Biosci ,2012,37(2) :289-294.
  • 3Wolin KY, Carson K, Colditz GA. Obesity and cancer[ J ]. Oncol- ogist,2010,15 (6) :556-565.
  • 4Jarde T, Perrier S, Vasson MP, et al. Molecular mechanisms of leptin and adiponectin in breast cancer[ J ]. Eur J Cancer, 2011, 47(1) :33-43.
  • 5Binai NA,Damert A,Carra G,et al. Expreesion of estrogen recep- tor alpha increases leptin-induced STAT3 activity in breast cancer [J]. Int J Cancer,2010,127( 1 ) :55-66.
  • 6Saxena NK, Vertinno PM, Anania FA, et al. Leptin-induved growth stimulation of breast cancer ceils involves recruitment of histone acetyltransferases and mediator complex to CYCLINDI promoter via activation of STAT3[J]. Biol Chem,2007,282(18) :13316-13325.
  • 7Jarde T,Gladefie-Chezet F,Gonealves-Mendes N,et al. Involve- ment of adiponectin and leptin in breast cancer:clinical and in vitro studies [ J ]. Endocr Relat Cancer,2009,16 (4) : 1197-1210.
  • 8Schepelman S, Ogilvie LM, Hedley D, et al. Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic asenovirus expressing carboxypeptidase G2 [ J ]. Cancer Res, 2007,67 (10) :4949-4955.
  • 9Frank DA. STAT3 as a central mediator of neoplastic cellular trans- formation[J]. Cancer Lett ,2007 ,251 (2) :199-210.
  • 10Gao Q, Mezei G, Nie Y, et al. Anorectic estrogen mimics leptin' s effect on the rewiring of melanocortin cells, STAT3 signaling in obese animals[ J]. Nat Med ,2007,13 (1) :89-94.

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部